Deep brain stimulation (DBS) is a surgical treatment that uses electrical impulses to influence the activity of specific brain circuits. It can help people with certain neurological disorders, particularly Parkinson’s disease, essential tremor, and dystonia, when symptoms remain difficult to control with medication. It is also used for selected cases of epilepsy and obsessive-compulsive disorder.
The treatment involves placing thin electrodes in carefully chosen areas of the brain and connecting them to a small, programmable device that delivers electrical stimulation. Unlike surgery that removes or destroys brain tissue, DBS is designed to change how neural circuits function without intentionally damaging the targeted area. Its effects can often be adjusted by changing the stimulation settings, and the system can be turned off.
DBS does not cure the underlying disorders it treats. Instead, it can reduce specific symptoms, improve daily functioning, and, for some patients, make it easier to maintain independence. Its benefits depend on the condition being treated, the brain region stimulated, and the individual’s response.
Understanding how DBS works requires looking at how the brain coordinates movement, behavior, and other functions—and what happens when the circuits responsible for these processes become disrupted.
What is deep brain stimulation?
The brain communicates through networks of nerve cells, called neurons, that transmit electrical signals and communicate chemically at connections known as synapses. These signals allow different brain regions to coordinate movement, process information, regulate emotions, and carry out other functions.
Many neurological and psychiatric disorders involve changes in the activity or communication of these networks. Symptoms may arise not only because particular neurons are damaged or lost, but also because the signals traveling through connected brain regions become abnormal.
Deep brain stimulation uses controlled electrical stimulation to influence selected networks. The goal is to alter the patterns of activity that contribute to symptoms while preserving as much normal brain function as possible.
A DBS system generally has three main components:
- Electrodes: Thin wires with electrical contacts are implanted in a specific brain region. These contacts deliver stimulation to nearby neural tissue.
- Extension wires: Wires run beneath the skin, connecting the electrodes to the implanted pulse generator.
- Implanted pulse generator: This battery-powered device, usually placed beneath the skin in the chest or sometimes elsewhere, produces the electrical pulses. A clinician can adjust its settings using an external programming device.
Some systems use rechargeable batteries, while others require periodic replacement when the battery runs down. The exact design depends on the device and the patient’s needs.
The electrodes are positioned using detailed brain imaging and surgical planning. Depending on the condition and treatment plan, a person may receive electrodes on one side of the brain or both sides.
After implantation, clinicians program the device to find settings that provide the greatest symptom relief with acceptable side effects. This process can take multiple visits because the optimal stimulation parameters vary from person to person.
How deep brain stimulation works
The effects of DBS are more complex than simply switching a brain region on or off. Electrical stimulation influences nearby neurons, their connections, and the signals traveling through the larger networks to which they belong.
Researchers have not established one complete mechanism that explains every effect of DBS. However, several processes help explain how it can improve symptoms.
Changing abnormal neural activity
In conditions such as Parkinson’s disease, the loss of certain dopamine-producing neurons alters communication among brain regions involved in movement. These changes can produce abnormal patterns of neural activity, making it harder to initiate and coordinate voluntary movements.
DBS delivers repeated electrical pulses to a selected target, often within circuits involving the basal ganglia. The basal ganglia are a group of interconnected structures that help regulate movement and other functions.
Stimulation can influence the timing and pattern of electrical signals in these circuits. It may change the activity of neurons near the electrode, affect the transmission of signals along nerve fibers, and alter communication between connected brain regions.
The result is not necessarily an increase or decrease in activity everywhere. Rather, stimulation can reorganize aspects of neural signaling in ways that reduce the abnormal circuit activity contributing to a particular symptom.
Why the target matters
The brain contains many interconnected networks, but different regions contribute to different functions. A stimulation target that improves tremor may not be the best target for stiffness, involuntary movements, or psychiatric symptoms.
For example, the subthalamic nucleus and the globus pallidus interna are two structures commonly targeted for Parkinson’s disease. Both participate in movement-related circuits, but stimulation at these sites can have different effects on motor symptoms, medication requirements, and certain side effects.
For essential tremor, a target within the thalamus or its connections to the cerebellum is commonly used. These pathways help coordinate movement, and abnormal signaling within them contributes to tremor.
Choosing a target involves considering the person’s diagnosis, most troublesome symptoms, other medical conditions, likely benefits, and potential risks. Precise placement is important because nearby brain structures and nerve pathways can serve very different functions.
How electrical stimulation affects the brain
DBS devices deliver electrical pulses characterized by parameters such as frequency, pulse width, and amplitude. These describe how often pulses occur, how long each pulse lasts, and the strength of the stimulation.
Clinicians adjust these parameters to influence which neural elements are recruited and how the surrounding circuits respond. The best settings depend on the electrode’s location and the patient’s symptoms and tolerance.
Because stimulation acts on networks rather than a single isolated group of cells, its effects can extend beyond the tissue immediately surrounding an electrode. This network-level influence is an important part of both the treatment’s effectiveness and its potential side effects.
DBS differs from medications in a fundamental way. A medication may affect chemical signaling across many parts of the body and brain, whereas DBS delivers electrical stimulation to a selected neural target. Neither approach is universally better; their usefulness depends on the disorder and the individual.
What conditions can deep brain stimulation treat?
DBS is an established treatment for several conditions, but its role varies considerably. For some disorders, it is a well-established option for appropriately selected patients. For others, it is reserved for severe cases, remains under investigation, or is available only under specific regulatory or clinical circumstances.
Parkinson’s disease
Parkinson’s disease is a progressive neurological disorder associated with the loss of dopamine-producing neurons, particularly those in a region called the substantia nigra. Dopamine helps regulate the brain circuits responsible for smooth, coordinated movement.
As dopamine signaling declines, people may develop tremor, muscle rigidity, slowed movement, and difficulties with balance and walking. Medication, especially levodopa, can improve many of these symptoms, but its effects may become less predictable as the disease progresses. Some patients experience periods when medication works well and periods when symptoms return. Others develop involuntary movements known as dyskinesias.
DBS can help reduce several of the main movement symptoms of Parkinson’s disease, including tremor, rigidity, and slowness of movement. In appropriately selected patients, it can also reduce medication-related fluctuations and certain dyskinesias, sometimes allowing medication doses to be reduced.
DBS does not stop the degeneration of dopamine-producing neurons. It also does not reliably improve every symptom of Parkinson’s disease. Problems such as dementia, some forms of balance impairment, speech difficulties, and autonomic symptoms may respond poorly or may worsen in certain circumstances.
People who respond well to levodopa often experience meaningful improvement in the symptoms that respond to the medication, although tremor that is resistant to medication can be an important exception. The decision to pursue surgery depends on the person’s overall health, symptom pattern, cognitive status, and treatment goals.
Essential tremor
Essential tremor is a neurological movement disorder that causes involuntary, rhythmic shaking. It often affects the hands and arms, making activities such as writing, drinking from a cup, eating, or using tools difficult. It can also affect the head or voice.
Medication helps some people, but others continue to experience disabling tremor despite treatment or cannot tolerate the available drugs.
DBS can reduce tremor by stimulating neural circuits involved in movement coordination, commonly through a target in the thalamus or connected pathways. The improvement can make everyday activities easier, although the degree of benefit varies.
Stimulation settings may need adjustment over time. Side effects can include speech changes, balance difficulties, or tingling, depending on the target and the spread of stimulation.
Essential tremor can affect both sides of the body, but treating both sides of the brain may carry additional risks. The treatment plan must balance symptom relief against the possibility of unwanted effects.
Dystonia
Dystonia causes involuntary muscle contractions that produce twisting movements, abnormal postures, or repetitive movements. It can affect one part of the body, such as the neck, or involve multiple regions.
The disorder is associated with abnormal activity in networks that coordinate movement, including connections among the basal ganglia, thalamus, and cortex.
DBS, often targeting the globus pallidus interna, can reduce dystonic movements and postures in selected patients. It is particularly useful for some forms of generalized or severe dystonia that have not responded adequately to other treatments.
Improvement may develop gradually over weeks or months rather than immediately. Outcomes depend on the cause of the dystonia, how long symptoms have been present, and whether fixed changes in muscles or joints have developed.
DBS does not benefit every form of dystonia equally. The underlying diagnosis and the likelihood of a favorable response are central to determining whether surgery is appropriate.
Epilepsy
Epilepsy is a neurological disorder characterized by a tendency to experience recurrent seizures. Seizures occur when groups of neurons produce abnormal electrical activity that disrupts normal brain function.
Many people achieve good seizure control with antiseizure medication. For those whose seizures continue despite appropriate treatment, evaluation at a specialized epilepsy center may identify additional options, including surgery, dietary therapy, nerve stimulation, or other forms of neuromodulation.
DBS can be used in selected patients with difficult-to-treat epilepsy. One established approach targets the anterior nucleus of the thalamus, a structure connected to networks involved in seizure activity.
Rather than removing the area where seizures begin, this approach delivers stimulation to influence seizure-related networks. The aim is to reduce seizure frequency and severity over time.
DBS is not a cure for epilepsy, and it does not eliminate seizures in every patient. Benefits may develop gradually, and treatment generally remains part of a broader management plan that can include medication and ongoing neurological care.
Obsessive-compulsive disorder
Obsessive-compulsive disorder (OCD) involves persistent, unwanted thoughts or urges called obsessions and repetitive behaviors or mental acts called compulsions. These symptoms can consume substantial time and interfere with work, relationships, and daily life.
OCD is associated with altered communication in brain circuits involved in evaluating threats, processing rewards, regulating habits, and controlling behavior. Treatments such as exposure and response prevention, a specialized form of cognitive behavioral therapy, and medication help many people. Some continue to experience severe symptoms despite extensive treatment.
DBS may be considered for a small, carefully selected group of adults with severe, chronic, treatment-resistant OCD. Electrodes are placed in a target within a network involved in the disorder, with the aim of changing activity that contributes to persistent obsessions and compulsions.
The effects are less predictable than the motor benefits seen in some movement disorders. Improvement may require careful programming, time, and continued psychiatric treatment. Because OCD involves complex emotional and cognitive processes, assessing benefits and side effects requires specialized expertise.
DBS for OCD is not a routine first-line treatment. Its use is subject to specific regulatory requirements and clinical criteria, which can differ from those for movement disorders.
Other conditions under investigation
Researchers are studying DBS for other neurological and psychiatric conditions, including certain forms of chronic pain, depression, and disorders involving impaired movement or behavior.
However, promising results in a research setting do not automatically establish a treatment as safe and effective for routine clinical use. A condition may have several biological causes, and stimulating a particular circuit may help some patients while providing little benefit to others.
For any proposed use, it is important to distinguish an established indication from an investigational application. Treatment availability, evidence, and regulatory status can change as research develops.
Who may be a candidate for deep brain stimulation?
DBS is generally considered when symptoms significantly affect a person’s quality of life and other treatments have not provided sufficient benefit or have caused unacceptable side effects. The criteria depend on the condition.
For Parkinson’s disease, for example, clinicians may consider DBS when medication produces disabling fluctuations, dyskinesias, or persistent tremor. A person does not necessarily need to be in the late stages of the disease, but the expected benefits must outweigh the risks.
Candidacy usually requires a comprehensive assessment involving relevant specialists, such as neurologists, neurosurgeons, psychiatrists, neuropsychologists, and rehabilitation professionals.
The evaluation may include:
- Confirmation of the diagnosis: Symptoms that resemble a treatable disorder can sometimes have another cause. A clear diagnosis is essential because DBS is effective only for particular conditions and symptom patterns.
- Review of previous treatments: Clinicians assess medication response, treatment duration, side effects, and whether other options remain appropriate.
- Cognitive and psychiatric assessment: Memory problems, impaired judgment, severe untreated psychiatric symptoms, or other concerns may affect safety, decision-making, and expected outcomes.
- Medical and surgical assessment: The team evaluates general health, bleeding risk, infection risk, and the person’s ability to undergo surgery and follow-up care.
- Discussion of goals and expectations: Patients and clinicians identify which symptoms matter most and which are realistically likely to improve.
Age alone does not determine eligibility. Overall health, the condition being treated, cognitive function, symptom characteristics, and personal circumstances are often more important.
It is equally important to understand what DBS is unlikely to change. A person may experience substantial improvement in one symptom while continuing to need medication, physical therapy, psychological treatment, or assistance with daily activities.
What happens during DBS surgery?
DBS requires surgery because the electrodes must be placed inside the brain. The procedure is carefully planned, and the details vary according to the condition, the target, the device, and the surgical team’s approach.
Before surgery, clinicians use brain imaging to identify the intended target and plan a safe route for electrode placement. Computer-guided systems help translate this plan into precise surgical coordinates.
During implantation, the surgeon creates a small opening in the skull and advances an electrode to the selected brain region. Some procedures involve testing stimulation during surgery to assess effects on symptoms or identify unwanted responses. Depending on the technique and the patient, surgery may be performed while the person is awake or under general anesthesia.
Awake procedures can allow clinicians to assess movement, speech, or other functions during electrode placement. General anesthesia is appropriate for many procedures, and modern imaging and surgical guidance can support accurate placement without requiring the patient to remain awake throughout.
Once the electrodes are in place, extension wires connect them to the pulse generator, which is typically implanted beneath the skin of the chest. The incisions are then closed.
The procedure carries risks, including bleeding in or around the brain, infection, seizures, complications related to anesthesia, and problems involving the implanted hardware. Although serious complications are not inevitable, they must be considered carefully before surgery.
Programming and life after implantation
Implantation is only one part of DBS treatment. The device must be programmed, symptoms monitored, and settings adjusted to achieve an appropriate balance between benefit and side effects.
Initial programming generally takes place after surgery, according to the treatment team’s plan. Clinicians adjust the electrical stimulation parameters and evaluate how symptoms respond. Finding an effective combination can require several visits because benefits and side effects may emerge at different settings.
A setting that reduces tremor, for example, might also cause tingling or affect speech if stimulation reaches nearby structures. Adjusting the electrode contact or changing the stimulation parameters may improve the balance.
Some patients notice changes relatively quickly, while others require a longer period of optimization. Dystonia and certain other conditions may improve gradually. Medication adjustments, when appropriate, are coordinated with the clinical team rather than made independently.
DBS is a long-term treatment. Patients generally need periodic follow-up to monitor symptoms, assess side effects, check the device, and review battery status. Some systems allow patients to make limited adjustments within clinician-defined settings, but those controls do not replace professional programming.
The device can often be switched off, although symptoms may return when stimulation stops. The effects of turning it off depend on the disorder and the individual. Sudden interruption of stimulation can be dangerous in some circumstances, so patients should follow their clinical team’s instructions if a device malfunctions or its battery is depleted.
DBS does not eliminate the need for regular medical care. The underlying disorder may continue to progress, and new symptoms may arise even when stimulation remains effective for the symptoms it was designed to treat.
What are the risks and side effects of DBS?
The risks of DBS fall into several broad categories: complications from surgery, problems with the implanted system, and unwanted effects of electrical stimulation.
Surgical complications can include bleeding, infection, and injury to nearby brain structures. Bleeding can occasionally cause a stroke or lasting neurological impairment. Hardware complications may include wire breakage, movement of an electrode, skin erosion, or infection that requires treatment or device removal.
Electrical stimulation can cause side effects because the targeted brain regions are connected to other systems or lie near structures responsible for different functions. Depending on the target, these effects may include tingling, muscle contractions, changes in speech, impaired balance, visual disturbances, mood changes, or cognitive difficulties.
Some side effects improve when stimulation settings are changed. Others may persist, and not every problem can be resolved through programming.
Cognitive and psychiatric effects deserve particular attention. Some patients may experience changes in mood, motivation, impulse control, or thinking. The likelihood and nature of these effects depend on factors such as the condition, target, stimulation settings, and individual vulnerability.
Battery depletion and device malfunction can also affect treatment. For patients who depend heavily on stimulation, interruption may cause substantial symptom worsening. The clinical team provides guidance on monitoring the device and responding to alerts or unexpected changes.
Before surgery, patients should discuss the specific risks relevant to their diagnosis and proposed target. The potential benefits must be weighed against the possibility of complications, the demands of long-term follow-up, and the fact that symptom improvement is not guaranteed.
How DBS differs from other treatments
DBS is one of several approaches used to manage neurological disorders. Its role becomes clearer when compared with medication, destructive brain surgery, and other forms of neuromodulation.
Medication changes chemical signaling in the body or brain. It is often the first treatment for movement disorders because it can improve symptoms without surgery. However, medication may cause systemic side effects, become less effective for certain symptoms, or produce fluctuations as a disorder progresses.
Ablative surgery intentionally destroys or permanently lesions a small area of tissue to interrupt a problematic circuit. Like DBS, it can improve selected symptoms, but the resulting tissue change cannot simply be reversed by turning a device off. The suitability of ablative procedures depends on the disorder and the treatment goal.
Other forms of neuromodulation influence nervous system activity without placing electrodes deep inside the brain. For example, vagus nerve stimulation uses an implanted device to stimulate the vagus nerve, while transcranial magnetic stimulation applies magnetic pulses from outside the head. These methods differ in their targets, mechanisms, risks, and established uses.
A major advantage of DBS is that its stimulation can be adjusted over time. If symptoms change or side effects develop, clinicians may modify the settings or, in some circumstances, turn the system off. However, the treatment is not fully reversible in every sense: the surgical procedure has already occurred, and complications or lasting effects can still happen.
The best approach depends on the disorder, the symptoms that need treatment, previous responses, medical risks, and the patient’s preferences.
What scientists still do not fully understand
DBS has transformed treatment for certain disorders, yet its mechanisms remain an active area of neuroscience research.
One challenge is that electrical stimulation affects a complex mixture of neurons, nerve fibers, and interconnected circuits. The same stimulation can influence several pathways at once, and those pathways may contribute differently to symptom improvement and side effects.
Researchers are investigating how stimulation changes the timing and coordination of neural signals, how its effects spread through brain networks, and why particular targets work better for certain symptoms. Understanding these processes may help clinicians personalize treatment more effectively.
Another area of development involves adaptive or responsive stimulation. Conventional DBS typically delivers stimulation according to programmed settings, whether or not symptoms are changing at that moment. Adaptive approaches aim to adjust stimulation in response to signals that reflect the brain’s changing state.
Such systems may eventually improve efficiency or reduce side effects for some conditions, but their usefulness depends on the ability to identify meaningful brain signals and reliably connect them to treatment adjustments. Their role varies by disorder and technology, and they should not be assumed to replace conventional DBS in routine care.
The broader scientific challenge is to understand neurological and psychiatric disorders as problems involving networks rather than isolated structures. DBS provides both a treatment and a way to study these networks: changing activity in a selected circuit can reveal how that circuit contributes to movement, behavior, and other brain functions.
Deep brain stimulation is therefore neither a universal solution nor a simple electrical switch. It is a targeted, adjustable treatment that can substantially improve selected symptoms when the underlying condition, neural target, and patient characteristics align. Its value lies in influencing the brain’s own communication systems while leaving the larger structure of the brain intact, with benefits and limitations that must be evaluated for each individual.
